Alterations in CD4+, CD8+, Vγ3, Vγδ, and/or Vαβ T-lymphocyte expression in lymphoid tissues of progeny after in utero exposure to benzo(α)pyrene

Journal of Immunotoxicology

Volumn 5, Issue 3, 2008, Pages 293-306

  Urso, P ^a,c   Wirsiy, Y G ^a   Zhang, W ^a   Moolenaar Wirsiy, P J ^b  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

^b CLARK ATLANTA UNIVERSITY   (United States)

^c NONE   (United States)

Author keywords

Benzo( )pyrene; Fetal liver; Immunosuppression; Spleen; T lymphocytes; Thymus

Indexed keywords

BENZO[A]PYRENE 7,8 DIHYDRODIOL 9,10 OXIDE; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CONCANAVALIN A; CORN OIL; EPOXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; C3H MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELL ISOLATION; CHEMICAL CARCINOGENESIS; EXCISION; FEMALE; FETUS; FETUS LIVER; FLOW CYTOMETRY; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; IMMUNOTOXICITY; INJECTION; LYMPHOID TISSUE; MALE; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; PREGNANCY; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROGENY; QUANTITATIVE ANALYSIS; SPLEEN; T LYMPHOCYTE; TUMOR GROWTH;

ANIMALS; ANIMALS, SUCKLING; ANTIGENS, CD4; ANTIGENS, CD8; ANTIGENS, THY-1; BENZO(A)PYRENE; CELL TRANSFORMATION, NEOPLASTIC; EMBRYO, MAMMALIAN; FEMALE; FETUS; LYMPHOID TISSUE; MALE; MATERNAL EXPOSURE; MICE; MICE, INBRED C3H; PREGNANCY; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTE SUBSETS; UTERUS;

MUS; ZEA MAYS;

EID: 53149153879     PISSN: 1547691X     EISSN: 1547691X     Source Type: Journal    
DOI: 10.1080/15376510802312324     Document Type: Article

References (62)

1. Adler, I. D. 1983. New approaches to mutagenicity studies in animals for carcinogenic and mutagenic agents. Clastogenic effects determined in transplacentally-treated mouse embryos. Teratogen, Carcinogen, Mutagen. 3:321-334.
2. Alam, S. M., Clark, J. S., Leech, V., Whitford, P., George, W. D., and Campbell, A. M. 1992. T-Cell receptor γ/δ expression on lymphocyte populations of breast cancer patients. Immunol. Lett. 31:279-283.
3. Asarnow, D. M., Goodman, T., Lefrancois, L., and Allison, J. 1999. Distinct antigen receptor repertoires of two classes of murine epithelium-associated T-cells. Nature 341:60-62.
4. Bartholomew, J. C., Salmon, A. G., Gamper, H. B., and Calvin, M. 1975. Benzo(α)pyrene effects on mouse epithelial cells in culture. Cancer Res. 35:851-856.
5. Besteman, E. G., Zimmerman, K. L., and Holladay, S. D. 2005. Tetrachlorobenzo-p-dioxin (TCDD) inhibits differentiation and increases apoptotic cell death of precursor T-cells in the fetal mouse thymus. J. Immunotoxicol. 2:107-114.
6. Bolognesi, C., Rossi, L., Barbieri, O., and Santi, L. 1985. Benzo(α)pyrene induced DNA damage in mouse fetal tissues. Carcinogenesis 6:1091-1095.
7. Dean, J. H., Luster, M. I., Boorman, G. A., Lauer, L. D., Luebke R. W., and Lawson, L. 1983. Immune suppression following exposure of mice to the carcinogen benzo(α)pyrene but not to the non-carcinogenic benzo(α)pyrene. Clin. Exp. Toxicol. 52:199-206.
8. Douagi, I., Colucci, F., DiSanto, J. P., and Cumano, A. 2002. Identification of the earliest prethymic bipotent T/NK progenitor in the murine fetal liver. Blood 99:463-471.
9. Faas, S. J., Rothstein, J. L., Kreider, B. L., Rovera, G., and Knowles, B. B. 1993. Phenotypically diverse mouse thymic stromal cell lines which induce proliferation and differentiation of hematopoietic cells. Eur. J. Immunol. 23:1201-1214.
10. Feng, Y., Shi, G., Wu, J., Wang, Y., Zhu, T., Dai, S., and Pei, Y. 2007. Source analysis of particulate-phase polycyclic aromatic hydrocarbons in an urban atmosphere of a northern city in China. J. Air Waste Manage. Assoc. 57:164-171.
11. Fine, J. S., Gasiewicz, T. A., and Silverstone, A. E. 1989. Lymphocyte stem cell alterations following perinatal exposure to 2,3,7,8- tetrachlorodibenzo-p-dioxin. Mol. Pharmacol. 35:18-25.
12. Girardi, M., Glusac, E., Filler, R. B., Roberts, S. J., Propperova, I., Lewis, J., Tigelaar, R. E., and Hayday, C. 2003. The distinct contributions of murine T-cell receptor TCRγδ and TCRαβ T-cells to different stages of chemically induced skin cancer. J. Exp. Med. 198:747-755.
13. Gregoire, K. E., Goldschneider, I., Barton, R. W., and Bollum, F. J. 1977. Intracellular distribution of terminal deoxynucleotidyl transferase in rat bone marrow and thymus. Proc. Natl. Acad. Sci. USA 74:3993-3996.
14. Haks, M. C., Cordaro, T. A., van den Brakel, J. H., Haanen, J. B., de Vries, E. F., Borst, J., Krimpenfort, P., and Kruisbeek, A. M. 2001. A redundant role of CD3γ-immunoreceptor tyrosine-based activation motif in mature T-cell function. J. Immunol. 166:2576-2588.
15. Havran, W. L., and Allison, J. P. 1988. Developmentally ordered appearance of thymocytes expressing different T-cell antigen receptors. Nature 335:443-446.
16. Heidel, S. M., Holston, K., Buters, J. T., Gonzalez, F. J., Jefcoate, C. R., and Czupyrynski, C. J. 1999. Bone marrow stromal cell cytochrome P4501B1 is required for pre-B-cell apoptosis induced by 3,12-dimethylbenz(a)anthracene. Mol. Pharmacol. 56:1317-1323.
17. Holladay, S. D., and Luster, M. I. 1996. Alterations in fetal thymic and liver hematopoietic cells as indicators of exposure to developmental immunotoxicants. Environ. Health Perspect. 104(S4): 809-813.
18. Holladay, S. D., and Smith, B. J. 1994. Fetal hematopoietic alterations after maternal exposure to benzo(α)pyrene: A cytometric evaluation. J. Toxicol. Environ. Health 42:259-273.
19. Ikuta, K., Kina, T., MacNeil, I., Uchida, N., Peault, B., Chien, Y. H., and Weissman, I. L. 1992. Development of γδ T-cell subsets from fetal hematopoietic cells. Ann. N.Y. Acad. Sci. 651:21-32.
20. Jones, S. L., Johnson, R. A., and Urso, P. 1986. Observations on B-cells of progeny and mothers exposed to benzo(α)pyrene at mid-gestation. Fed. Proc. 45:25. (Proceedings)
21. Kapitulnik, J., Levin, W., Conney, A. H., Yagi, H., and Jerina, D. M. 1977. Benzo(α)pyrene 7,8-dihydrodiol-9,10-epoxide is more carcinogenic than benzo(α)pyrene in new born mice. Nature 266:378-380.
22. 3 cells in IL-2 stimulated fetal thymocytes. J. Immunol. 145:3992-3997.
23. Lee, M., Kirlin, W., Sturrup, M., Rodriguez, J., and Urso, P. 1996. Variation in the response of T-cells to Concanavalin A afterin vitro exposure to benzo(α)pyrene and 2-aminofluorene. Immunopharm. Immuntox. 18:309-321.
24. Legraverend, C., Guenthner, T. M., and Nebert, D. W. 1984. Importance of the route of administration for genetic differences in benzo[α]pyrene- induced in utero toxicity and teratogenicity. Teratology 29:35-47.
25. Lu, L. J., and Wang, M. Y. 1990. Modulation of benzo(ε)pyrene- induced covalent DNA modifications in adult and fetal mouse tissue by gestation stage. Carcingenesis 8:1367-1372.
26. Lu, L. J., Anderson, L. M., Jones, A. B., Maskal, T. J., Salazar, J. J., Hokanson, J. A., and Rice, T. M. 1993. Persistence, gestation-stage-dependent formation and interrelationship of benzo(α)pyrene-induced DNA adducts in mothers, placentae, and fetuses of Erythrocebus patas monkeys. Carcinogenesis 14:1805-1813.
27. Luch, A., and Baird, W. M. 2005. Metabolic activation and detoxification of polycyclic aromatic hydrocarbons. In: The Carcinogenic Effects of the Polycyclic Aromatic Hydrocarbons (Luch, A., Ed.), Imperial College Press: London, pp. 19-96.
28. Lummus, Z. L., and Henningsen, G. 1995 Modulation of T-cell ontogeny by transplacental benzo(α)pyrene. Int. J. Immunopharmacol. 17:339-350.
29. Lundberg, P., and Splitter, G. A. 2000. γδ T-lymphocyte cytotoxicity against envelope-expressing target cells is unique to the alymphocytic state of bovine leukemia virus infection in the natural host. J. Virol. 74:8299-8306.
30. Lyte, M. L., Blanton, R. H., Myers, M. J., and Bick, P. H. 1987. Effect of in vivo administration of the carcinogen benzo(α)pyrene on IL-2 and IL-3 production. Int. J. Immunopharmacol. 9:307-315.
31. Matis, L. A., Cron, R., and Bluestone, J. A. 1987. Major histocompatability complex-linked specificity of γδ receptor-bearing T-lymphocytes. Nature 330:262-264.
32. Mattison, D. R., White, N. B., and Nightingale, M. R. 1980. The effect of benzo(α)pyrene on fertility, primordial oocyte number, and ovarian response to pregnant mare's serum gonadotropin. Pediat. Pharmacol. 1:143-151.
33. Mertsching, E., Wurster, A. L., Katayama, C., Esko, J., Ramsdell, F., Marth, J. D., and Hedrick, S. M. 2002. A mouse strain defective for α,γ δ T-cell lineage. Int. Immunol. 14:1039-1053.
34. + distinguished in early growth response-1 transgenic mice with recombinase-activating gene-deficient background. J. Exp. Med. 6:877-885.
35. Moolenaar, P., Wirsiy, Y. G., Rodriguez, J., Zhang, W., Lee, M., and Urso, P. 1996. Dysfunctional T-cells induced by benzo(α)pyrene express BPDE-DNA adducts. AACR 75:648.
36. + SP and DP (γ δ, αβ) T-cells expressing BPDE-DNA adducts in progeny of mouse dams exposed to benzo(α)pyrene at mid-gestation. J. Immunotoxicol. 4:267-278.
37. Nikinova, T. V. 1977. Placental action of benzo(α)pyrene and pyrene. Bull. Exp. Biol. Med. 84:1025-1027.
38. Peck, A. B., and Bach, F. H. 1973. A miniaturized mouse lymphocyte culture in serum-free and mouse serum supplemented media. J. Immunol. Meth. 3:147-164.
39. Penninger, J., Kishihara, K., Kow, D. R., Pfeffer, K., Wallace, V. A., Young, R., Zhanke, B., and Mak, T. W. 1994. T-Cell receptor: Recognition of antigens and signal transduction. In: Immunopharmacology of Lymphocytes (Pleszczynski, M. R., Ed.), Academic Press: New York, pp. 41-122.
40. Raspollini, M. R., Castiglone, F., Rossi Degl'Innocenti, D., Alumni, G., Villanucci, A., Garbini, F., Baroni, G., and Taddei, G. L. 2005. Tumor-infiltrating γ/δ-lymphocytes are correlated with a brief disease-free interval in advanced ovarian serous carcinoma. Ann. Oncol. 15:590-596.
41. Rodriguez, J. W., Kirlin, W. G., Wirsiy, Y. G., Matheravidathu, S., Hodge, T. W., and Urso, P. 1999. Maternal exposure to benzo[α]pyrene alters development of T-lymphocytes in offspring. Immunopharmacol. Immunotoxicol. 21:379-396.
42. + thymocytes and splenocytes following in utero exposure to benzo[α]pyrene. Immunopharmacol. Immunotoxicol. 24:365-381.
43. Ross, J., Nelson, G., Erexson, G., Kligerman, A., Earley, K., Gupta, R. C., and Nesnow, S. 1991. DNA adducts in rat lung, liver, and peripheral blood lymphocytes produced by IP administration of benzo(α)pyrene metabolites and derivatives. Carcinogenesis 12:195-1955.
44. Searle, C. E. 1984. Chemical Carcinogens. Wasshington, DC, American Chemical Society, pp. 51-501.
45. Shendrikova, A., and Aleksandrov, V. A. 1974. Comparative penetration of polycyclic hydrocarbons through the rat placenta into the fetus. Bull. Exp. Biol. Med. (USSR) 77:169-171.
46. Shultz, M. A., Morin, D., Chang, A. M., and Buckpitt, A. 2001. Metabolic capacities of CYP2F2 with various pulmonary toxicants and its relative abundance in mouse lung sub-compartments. J. Pharmacol. Exp. Ther. 296:510-519.
47. Shum, S., Jensen, N. M., and Nebert, D. W. 1979. The murine Ah locus: In utero toxicity and teratogenesis associated with genetic differences in benzo(α)pyrene metabolism. Teratology 20:365-376.
48. Terrence, K., Pavlovich, C. P., Matechak, E. O., and Fowlkes, B. J. 2000. Premature expression of T-cell receptor (TCR)α suppresses TCRγδ gene rearrangement but permits development of γ δ lineage cells. J. Exp. Med. 192:537-548.
49. Urso, P., Cobb, J. C., Kramer, K., Gilmour, T. R., Colley, D., and Ryan, M. C. 1989. Murine fetal liver LYT and L3T4 cell profiles. FASEB J. 3:A278.
50. Urso, P., Cobb, J. R., Thomas, K. L., Ryan, M. C., and Bedford, C. 1990. Immunofluorescent evidence for LYT, L3T4, and/or Ig cells in murine fetal liver. FASEB J. 4:A1731.
51. Urso, P., and Gengozian, N. 1980. Depressed humoral immunity and increased tumor incidence in mice following in utero exposure to benzo(α)pyrene. J. Toxicol. Environ. Health 6:569-576.
52. Urso, P., and Gengozian, N. 1984. Subnormal expression of cell-mediated and humoral immune responses in progeny disposed toward a high incidence of tumors after in utero exposure to benzo(α)pyrene. J. Toxicol. Environ. Health 14:569-584.
53. Urso, P., and Johnson, R. A. 1987. Early changes in T-lymphocytes and subsets of mouse progeny defective as adults in controlling growth of a syngeneic tumor after in utero insult with benzo(α)pyrene. Immunopharmacology 14:1-10.
54. Urso, P., Wirsiy, Y., Zhang, W., Rodriguez, J., and Moolenaar P. 1994. Persistent defective T-cell differentiation in mice exposed to benzo(α)pyrene in utero. FASEB J. 54:A482.
55. Urso, P., Zhang, W., and Cobb, J. R. 1992. Immunological consequences from exposure to benzo(α)pyrene during pregnancy. Scand. J. Immunol. 36(S11):203-206.
56. + hematopoietic stem cells constitute target for polycyclic aromatic hydrocarbons. J. Pharmacol. Exp. Ther. 314:693-702.
57. van Grevenynghe, J., Sparfel, L., Le Vee, M., Gilot, D., Drenou, B,, Fauchet, R., and Fardel, O. 2004. Cytochrome P450-dependent toxicity of environmental polycyclic aromatic hydrocarbons towards human macrophages. Biochem. Biophys. Res. Commun. 317:708-716.
58. Vesselinovitch, S. D. 1973. Comparative studies on perinatal carcinogenesis. In: Transplacental Carcinogenesis (Tomatis, L., and Mohr, U., Eds.), International Agency for Research on Cancer: Lyon, France, pp. 14-22.
59. Wang, M. Y., and Lu, L. J. 1990. Differential effect of gestation stage on benzo(α)pyrene-induced micronucleus formation and/or covalent DNA modifications in mice. Cancer Res. 50:2146-2151.
60. Wegener, A. K., Letourneur, M. K., Hoeveler, F., Brocker, A., Luton, F., and Malissen, B. 1992. The T-cell receptor/CD3 complex is composed of at least two autonomous transduction molecules. Cell 68:83-95.
61. Welch, R. M., Gommi, B., Alvares, A. P., and Conney, A. H. 1972. Effect of enzyme induction on the metabolism of benzo(α)pyrene and 3′-methyl-4-monomethylaminobenzene in the pregnant and fetal rat. Cancer Res. 32:973-978.
62. 3H]-benzopyrene to pregnant mice and rats: Incorporation of radioactivity into subcellular fractions of various tissues. Archiv. Geschwulstforsch. 2:95-106.